Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

H2 receptor antagonists.

J K Siepler, K D Campagna, P E Donahue

    American Journal of Hospital Pharmacy
    |February 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Histamine H2 receptor antagonists (H2 antagonists) effectively manage peptic ulcers and Zollinger-Ellison syndrome. Cimetidine shows promise for duodenal ulcers, gastric ulcers, and hypersecretory conditions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Serum amylase and lipase elevation is associated with intracranial events.

    The American surgeon·2001
    Same author

    Paraplegia after esophagectomy: who are the patients at risk?

    The Journal of thoracic and cardiovascular surgery·2001
    Same author

    Laparoscopic myotomy in achalasia: intraoperative evidence for myotomy of the gastric cardia.

    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2000
    Same author

    Parietal cell vagotomy versus vagotomy-antrectomy: ulcer surgery in the modern era.

    World journal of surgery·2000
    Same author

    Ulcer surgery and highly selective vagotomy--Y2K.

    Archives of surgery (Chicago, Ill. : 1960)·1999
    Same author

    Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin. Trovafloxacin Surgical Group.

    American journal of surgery·1999
    Same journal

    National health care reform, Part 2: Response to pharmacists.

    American journal of hospital pharmacy·1994
    Same journal

    Validity of originality assessment.

    American journal of hospital pharmacy·1994
    Same journal

    Unit dose dispensing of chromic phosphate P 32 suspension.

    American journal of hospital pharmacy·1994
    Same journal

    Hydralazine injection still available.

    American journal of hospital pharmacy·1994
    Same journal

    Improved extemporaneous formulation of cyclosporine ophthalmic drops.

    American journal of hospital pharmacy·1994
    Same journal

    Paclitaxel diluent and the case of the slippery spike.

    American journal of hospital pharmacy·1994
    See all related articles

    Area of Science:

    • Gastroenterology
    • Pharmacology

    Background:

    • Peptic ulcer disease and Zollinger-Ellison syndrome involve gastric acid hypersecretion.
    • Histamine H2 receptor antagonists represent a novel therapeutic class.

    Purpose of the Study:

    • To review the clinical applications of H2 antagonists in managing peptic ulcer disease and Zollinger-Ellison syndrome.
    • To describe the pharmacology and clinical use of specific H2 antagonists, including burimamide, metiamide, and cimetidine.

    Main Methods:

    • Literature review of histamine H2 receptor antagonists.
    • Discussion of drug secretion, pharmacology, and clinical efficacy.
    • Analysis of side effects associated with H2 antagonist therapy.

    Main Results:

    Related Experiment Videos

  • H2 antagonists are effective in treating gastric hyperacidity and hypersecretory states.
  • Cimetidine demonstrates efficacy in treating duodenal ulcers.
  • Cimetidine shows promising results for Zollinger-Ellison syndrome and gastric ulceration.
  • Conclusions:

    • Histamine H2 receptor antagonists are valuable tools in managing peptic ulcer disease.
    • Cimetidine is a key H2 antagonist with significant therapeutic potential in various gastrointestinal disorders.